Publications by authors named "Markus Alter"

Claim this Profile
A
ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography.
Fabian Heunisch, Lyubov Chaykovska, Gina von Einem, Markus Alter, Thomas Dschietzig

Medicine (Baltimore)· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography.
Lyubov Chaykovska, Fabian Heunisch, Gina von Einem, Markus L Alter, Carl-Friedrich Hocher

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
Oleg Tsuprykov, Ryotaro Ando, Christoph Reichetzeder, Karoline von Websky, Viktoriia Antonenko, Markus Alter

Kidney Int· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary ET-1 excretion after exposure to radio-contrast media in diabetic patients and patients with preexisting mild impaired renal function.
Fabian Heunisch, Gina von Einem, Markus Alter, Andreas Weist, Thomas Dschietzig

Life Sci· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy.
Yuliya Sharkovska, Christoph Reichetzeder, Markus Alter, Oleg Tsuprykov, Sebastian Bachmann

J Hypertens· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension.
Lyubov Chaykovska, Markus L Alter, Karoline von Websky, Margarete Hohmann, Oleg Tsuprykov

J Hypertens· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal and cardiac effects of DPP4 inhibitors--from preclinical development to clinical research.
Berthold Hocher, Christoph Reichetzeder, Markus L Alter

Kidney Blood Press Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy.
Markus L Alter, Ina M Ott, Karoline von Websky, Oleg Tsuprykov, Yuliya Sharkovska

Kidney Blood Press Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockade.
Ina M Ott, Markus L Alter, Karoline von Websky, Axel Kretschmer, Oleg Tsuprykov

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early urinary and plasma biomarkers for experimental diabetic nephropathy.
Markus L Alter, Axel Kretschmer, Karoline Von Websky, Oleg Tsuprykov, Christoph Reichetzeder

Clin Lab· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy.
Lyubov Chaykovska, Karoline von Websky, Jan Rahnenführer, Markus Alter, Susi Heiden

PLoS One· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage.
Yuliya Sharkovska, Philipp Kalk, Karoline von Websky, Katharina Relle, Thiemo Pfab, Markus Alter

Clin Lab· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin-1 overexpression restores diastolic function in eNOS knockout mice.
Nicolas Vignon-Zellweger, Katharina Relle, Elodie Kienlen, Markus Alter, Patrick Seider

J Hypertens· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner.
Philipp Kalk, Yuliya Sharkovska, Elena Kashina, Karoline von Websky, Katharina Relle, Markus Alter

Hypertension· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in rats.
Berthold Hocher, Susi Heiden, Karoline von Websky, Ayman M Arafat, Jan Rahnenführer, Markus Alter

PLoS One· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal and fetal PROGINS progesterone receptor polymorphism reduces the risk for transient tachypnea of the newborn.
Markus Alter, Thiemo Pfab, Florian Guthmann, Aline Burdack, Nina Kempiners

Clin Lab· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New evidence for the fetal insulin hypothesis: fetal angiotensinogen M235T polymorphism is associated with birth weight and elevated fetal total glycated hemoglobin at birth.
Ludwig Schlemm, Hannah M Haumann, Maja Ziegner, Bulza Stirnberg, Andreas Sohn, Markus Alter

J Hypertens· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1.
Dierk Thomas, Markus Khalil, Markus Alter, Patrick A Schweizer, Christoph A Karle

J Mol Cell Cardiol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skipping of Exon 1 in the KCNQ1 gene causes Jervell and Lange-Nielsen syndrome.
Joerg Zehelein, Sven Kathoefer, Markus Khalil, Markus Alter, Dierk Thomas

J Biol Chem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.
Claudia Kiesecker, Markus Alter, Sven Kathöfer, Edgar Zitron, Eberhard P Scholz

Naunyn Schmiedebergs Arch Pharmacol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
Dierk Thomas, Anna-Britt Wimmer, Christoph A Karle, Manuela Licka, Markus Alter

Cardiovasc Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis